SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

AP

487

Zoetis

ZTS

Zoetis develops and manufactures animal health medicines and vaccines that aim to help veterinarians, as well as livestock farmers.

Looking for leads, investment insights, or competitive intelligence?

CEO

Juan Ram�n Alaix

CEO Title

Chief Executive Officer & Director

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Parsippany, N.J.

Years on Fortune 500 List

1

Employees

10,000

Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$5,8259.8%
Profits ($M)$1,428.065.3%
Assets ($M)$10,777
Total Stockholder Equity ($M)$2,185
Profit Ratios
Profit as % of Revenues24.5%
Profits as % of Assets13.3%
Profits as % of Stockholder Equity65.4%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)2.93
EPS % Change (from 2017)67.4%
EPS % Change (5 year annual rate)23.7%
EPS % Change (10 year annual rate)-
Total Return
Total Return to Investors (2018)19.4%
Total Return to Investors (5 year, annualized)22.1%
Total Return to Investors (10 year, annualized)-
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Zoetis

Valeant Is Said to Be Hiring This Zoetis Exec as Its New CFO

He served as senior vice president of finance operations at Zoetis.

Read More →
Pfizer Breakup May Depend on Trump or Clinton Winning the Election

Splitting itself up could depend on the next President's tax plan.

Read More →
Bill Ackman Just Unloaded $800 Million in Shares of This Pharma Firm

The animal drug company Zoetis was spun off from Pfizer in 2013.

Read More →